Search Results - "Rojas, L. Gutiérrez"

Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review by Molero, P., Ramos-Quiroga, J. A., Martin-Santos, R., Calvo-Sánchez, E., Gutiérrez-Rojas, L., Meana, J. J.

“…Ketamine and its enantiomer S -ketamine (esketamine) are promising candidates to produce a rapid-onset antidepressant effect in treatment-resistant depression…”
Get full text

Risk factors for suicide in schizophrenia: systematic review and clinical recommendations by Popovic, D., Benabarre, A., Crespo, J. M., Goikolea, J. M., González-Pinto, A., Gutiérrez-Rojas, L., Montes, J. M., Vieta, E.

“…Objective To identify risk factors associated with suicide of patients with schizophrenia and provide clinical recommendations, which integrate research…”
Get full text

Prader–Willi syndrome in a large sample from Spain: general features, obesity and regular use of psychotropic medication by González‐Domenech, P. J., Gurpegui, M., González‐Domenech, C. M., Gómez‐González, S., Rustarazo, A., Ruiz‐Nieto, V., Carretero, M. D., Gutiérrez‐Rojas, L.

“…Background Prader–Willi syndrome (PWS), a genetically determined disorder, the most frequent cause of early onset obesity, is associated with physical and…”
Get full text

Psychometric instruments for the assessment of depressive symptoms in patients with delusional disorder: A systematic review by González-Rodríguez, A, Monreal, J.A., Porras-Segovia, A, Cervilla, J.A., Gutiérrez-Rojas, L

“…•Comorbid depression is frequent in patients suffering delusional disorder.•Assessment scales used in affective disorders and schizophrenia are applied to the…”
Get full text

Assessment of hospitalizations in schizophrenia patients treated with paliperidone 1-monthly (PP1M), paliperidone 3-monthly (PP3M), aripiprazole once-monthly (AOM) and other oral antipsychotics (OAP) in clinical practice by Rojas, L. Gutiérrez, Alonso, S. Sánchez, Dorado, M. García, Lopez, P.

“…IntroductionIt has been shown that long-acting treatments can significantly improve adherence, control symptom, and reduce the risk of relapse compared to oral…”
Get full text

Barriers and facilitators associated with pharmacological treatment in bipolar disorder patients by Partera, J.Á. Alcalá, Navas, A. Fontalba, Morales, M. Company, Guillena, S.L. Romero, Higueras, T. Gutiérrez, Cortés, F. Calera, Forés, S. Vicent, Rojas, L. Gutiérrez

“…IntroductionThe main factors that are involved in a correct adherence to the therapeutic recommendations in Bipolar Disorder includes aspects related to age,…”
Get full text

Corrigendum to “Spanish validation of the Barcelona TEMPS-A questionnaire in patients with bipolar disorder and general population” [J. Affect. Disord. 249 (2019) 199–207 (Apr 15)] by Jiménez, E., Bonnín, C.D.M., Solé, B., Sánchez-Moreno, J., Reinares, M., Torrent, C., Torres, I., Salagre, E., Varo, C., Ruíz, V., Giménez, A., Benabarre, A., Gutiérrez-Rojas, L., Cervilla, J., Sáiz, P.A., García-Portilla, M.P., Bobes, J., Amann, B.L., Martínez-Arán, A., Vieta, E.

Get full text

Endocrine biomarkers related to sleep-wake cycle and sleep disturbances in patients with bipolar disorder: A systematic review by Gonzalez-Blanco, L., Moya Lacasa, C., Jiménez-Fernández, S., Valtueña, M., Martinez-Cao, C., García Fernández, A., Saiz, P.A., Garcia-Portilla, M.P., Bobes, J., Gutierrez Rojas, L.

“…IntroductionSleep and circadian disturbances have been widely studied in patients with bipolar disorder (BD) (Duarte Faria et al., 2015; Gonzalez, 2014)…”
Get full text

Chronic obstructive pulmonary disease in severe mental illness: A timely diagnosis to advance the process of quitting smoking by Jaen-Moreno, M J, Feu, N, Del Pozo, G I, Gómez, C, Carrión, L, Chauca, G M, Guler, I, Montiel, F J, Sánchez, M D, Alcalá, J A, Gutierrez-Rojas, L, Molina, V, Bobes, J, Balanzá-Martínez, V, Ruiz-Rull, C, Sarramea, F

“…This study has two main objectives: to describe the prevalence of undetected chronic obstructive pulmonary disease (COPD) in a clinical sample of smokers with…”
Get full text

Epidemiology of depression in southern Spain by Porras Segovia, A, Calvo-Rivera, P, Aguado-Bailón, L, Gutiérrez-Rojas, L, Cervilla-Ballesteros, J

Get full text

Clinical experience with aripiprazole long-acting injection by Calvo Rivera, M.P, Girela Serrano, B, Porras Segovia, A, Gutiérrez Rojas, L

“…Introduction Aripiprazole long-acting injection is the latest long-acting injectable (LAI) antipsychotic medication released in the market which requires a…”
Get full text

P.3.b.001 Risk factors for suicide in schizophrenia: systematic review and clinical recommendations by Popovic, D, Benabarre, A, Crespo, J.M, Goikolea, J.M, González-Pinto, A, Gutiérrez-Rojas, L, Montes, J.M, Vieta, E

Get full text

Smoking in Bipolar Disorder Patients: the 3 A's Intervention at Community Mental Health by Sarramea Crespo, F, Rico del Viejo, A.B, Osuna Carmona, M.I, Toledano García, M.D, Notario Madueño, M.J, Gómez Moreno, C, Alcalá Partera, J, Millán Aguilar, V, Gutiérrez-Rojas, L

“…Introduction It is necessary to explore the possibilities of brief intervention of smoking cessation in bipolar disorder (BD) that may act on the level of…”
Get full text

Molecular mapping of Cg1, a gene for resistance to anthracnose (Colletotrichum sublineolum) in sorghum by Ramasamy, P, Menz, M. A, Mehta, P. J, Katilé, S, Gutierrez-Rojas, L. A, Klein, R. R, Klein, P. E, Prom, L. K, Schlueter, J. A, Rooney, W. L, Magill, C. W

“…Anthracnose, caused by the fungus Colletotrichum sublineolum is one of the most destructive diseases of sorghum and has been reported in most areas where the…”
Get full text

Tolerability and safety of long-acting injectable aripiprazole by Porras Segovia, A, Calvo Rivera, P, Girela Serrano, B, Gutierrez Rojas, L

“…Introduction Long-acting injectable aripiprazole is the most recently introduced depot treatment in schizophrenia. Objectives The objective of this study is to…”
Get full text

P.659 Predominant polarity related variables and the onset age of outpatients’ sample of bipolar disorders by Gutiérrez-Rojas, L., García-Jiménez, J., Muñoz-Jiménez, A., Jordán, G., Gurpegui, M.

Get full text

P.3.019 - Epidemiology of depression in southern Spain by Porras Segovia, A., Calvo-Rivera, P., Aguado-Bailón, L., Gutiérrez-Rojas, L., Cervilla-Ballesteros, J.

Get full text

Late-onset bipolar illness: Literature review and case report by García-Jiménez, J., Porras-Segovia, A., García-López, R., Muñoz-Negro, J.E., Gutiérrez-Rojas, L.

“…Late-onset bipolar-illness (LOBI) diagnosis comprises those patients whose first mania episode occurs aged 60 or older. Traditionally, it has been considered…”
Get full text

Epidemiological and clinical variables related with the predominant polarity on bipolar disorder: A systematic review by García-Jiménez, J., Porras-Segovia, A., Gota-Garcés, J.M., Muñoz-Negro, J.E., Gutiérrez-Rojas, L.

“…Type I and type II classification of bipolar disorder (BD) may not provide useful information to the clinician regarding epidemiological and clinical…”
Get full text

A case for considering differences between organic and psychogenic amnesia by García López, R., Gota Garcés, J.M., García Jiménez, J., Muñoz Negro, J.E., Gutiérrez-Rojas, L.

“…Medical record, general examination, laboratory findings, neuropsychological interview and multidisciplinary consideration are essential to establish…”
Get full text